Pulmonary rehabilitation

2021 ◽  
pp. 515-522
Author(s):  
Terry Robinson ◽  
Jane Scullion
Keyword(s):  
Lung Disease ◽  
Social Isolation ◽  
Pulmonary Rehabilitation ◽  
Social Performance ◽  
Depression And Anxiety ◽  
Respiratory Impairment ◽  
Follow Up Care ◽  
Set Up ◽  
Programme Of Care

Pulmonary rehabilitation (PR) is an important component in the management, care, and treatment of patients with chronic lung disease, particularly with COPD and increasingly in ILD. Breathlessness is a symptom of the underlying lung disease, and can result in reduced patient activity, which in turn reduces fitness, leads to social isolation, and can exacerbate depression and anxiety. PR is a multidisciplinary programme of care for patients with chronic respiratory impairment that is individually tailored and designed to optimize physical and social performance and autonomy. This chapter describes the rationale for PR, how to set up an effective rehabilitation regime through education and physical exercise, and how to provide follow-up care.

Respiratory issues in rehabilitation

2019 ◽  
pp. 233-250
Author(s):  
Manoj Sivan ◽  
Margaret Phillips ◽  
Ian Baguley ◽  
Melissa Nott
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cystic Fibrosis ◽  
Lung Disease ◽  
Pulmonary Rehabilitation ◽  
The Other ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Respiratory Impairment ◽  
Neurological Conditions ◽  
Respiratory Conditions

Respiratory aspects of rehabilitation fall into two broad and overlapping categories. One is that of pulmonary rehabilitation which traditionally has focused on exercise, behaviour change, and educational-based intervention for those with chronic lung disease, predominantly chronic obstructive pulmonary disease, but its efficacy has since been proven in other chronic respiratory conditions (e.g. asthma, interstitial lung disease, cystic fibrosis, bronchiectasis, lung transplantation, and pulmonary hypertension). The other is rehabilitation in the context of neurogenic respiratory impairment, which is relevant to persons with both degenerative and monophasic-onset neurological conditions. These categories are overlapping as techniques from one may have relevance to the other. This chapter describes these aspects, investigations, and interventions.

scholarly journals Respiratory Impairment, Limited Activity, and Pulmonary Rehabilitation in Patients with Interstitial Lung Disease

2021 ◽  
Author(s):  
Ryo KOZU ◽  
Kazuya SHINGAI ◽  
Masatoshi HANADA ◽  
Masato OIKAWA ◽  
Hiroki NAGURA ◽  
...  
Keyword(s):  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Pulmonary Rehabilitation ◽  
Respiratory Impairment

Efficacy of rituximab in slowing down progression of rheumatoid arthritis–related interstitial lung disease: data from the NEREA Registry

Rheumatology ◽  
2020 ◽  
Vol 59 (8) ◽  
pp. 2099-2108 ◽  
Author(s):  
Cristina Vadillo ◽  
Maria Asuncion Nieto ◽  
Fredeswinda Romero-Bueno ◽  
Leticia Leon ◽  
Olga Sanchez-Pernaute ◽  
...  
Keyword(s):  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Multivariate Regression ◽  
Regression Models ◽  
Vital Capacity ◽  
Clinical Course ◽  
Respiratory Impairment ◽  
Slowing Down ◽  
Independent Variable

Abstract Objectives To asses the clinical course in RA-related interstitial lung disease (RA-ILD) patients with and without rituximab (RTX). The influence of other variables was also evaluated. Methods A longitudinal multicentre study was conducted in RA diagnosed with ILD from 2007 until 2018 in Madrid. Patients were included in a registry [pNEumology RhEumatology Autoinmune diseases (NEREA)] from the time of ILD diagnosis. The main endpoint was functional respiratory impairment (FI), when there was a decline ≥5% in the predicted forced vital capacity compared with the previous one. Pulmonary function was measured at baseline and in follow-up visits every 6–12 months. The independent variable was therapy with RTX. Covariables included sociodemographic, clinical, radiological and other therapies. Survival techniques were used to estimate the incidence rate (IR) and 95% CI of functional impairment, expressed per 100 patient-semesters. Cox multivariate regression models were run to examine the influence of RTX and other covariates on FI. Results were expressed as the hazard ratio (HR) and CI. Results A total of 68 patients were included. FI occurred in 42 patients [IR 23.5 (95% CI 19, 29.1)] and 50% of them had FI within 1.75 years of an ILD diagnosis. A multivariate analysis showed that RTX exposure resulted in a lower risk of FI compared with non-exposure [HR 0.51 (95% CI 0.31, 0.85)]. Interstitial pneumonia, glucocorticoids, disease activity and duration also influenced FI. Conclusion RA-ILD patients deteriorate over time, with the median time free of impairment being <2 years. Patients exposed to RTX had a higher probability of remaining free of FI compared with other therapies. Other factors have also been identified.

scholarly journals Pulmonary Rehabilitation Results in Significant Effect on Physical Outcomes: Preliminary Data from the Saint John Regional Hospital, New Brunswick, Canada

2007 ◽  
Vol 30 (3) ◽  
pp. 43
Author(s):  
Stephen J. Mundle ◽  
Christopher M. Blanchard
Keyword(s):  
Repeated Measures ◽  
Pulmonary Rehabilitation ◽  
Small Sample Size ◽  
Exercise Adherence ◽  
Small Sample ◽  
Chronic Obstructive ◽  
Respiratory Impairment ◽  
Supervised Exercise ◽  
Physical Outcomes

Background: Current guidelines claim that pulmonary rehabilitation is a cost effective method for increasing exercise tolerance, decreasing hospitalization, and improving knowledge and quality of life in patients with chronic obstructive pulmonary disease. The purpose of the present study was to examine the changes in physical and psychological outcomes during and after completion of a pulmonary program. Methods: Between September 2004 and April 2006, 27 patients attended pulmonary rehabilitation. All patients were referred by a Respirologist and had moderate to severe respiratory impairment on pulmonary function testing. They attended 3 supervised exercise sessions per week for 10 weeks under the supervision of a nurse and physiotherapist. Education modules were provided by the physiotherapist and respiratory therapist to increase knowledge and independence with disease management. Data was collected pre and post program, and at 3 month and 6 month follow up visits. There were 16 patients (59.3%) who had complete data and attended all follow-up appointments. Outcomes included the six minute walk test (6MWT) and chronic respiratory questionnaire (CRQ). Follow up visits also assessed exercise adherence and readmissions for respiratory problems. Results: Repeated measures analysis of variance showed improvement in 6MWT and average metabolic equivalent (MET) from pre to post program (P < .05) which remained stable up to 6 months follow-up. The same analysis did not show improvement for any of the variables measured in the CRQ. Exercise routine, as reported by patients at 6 months, was 4.7 days per week for 28 minutes per session. Readmissions for pulmonary problems were reported by 3 patients, 2 at the 3 month assessment and 1 at the 6 month. Conclusions: Preliminary program results show improvement in physical outcomes and impressive exercise adherence at 6 months follow-up. The small sample size is an obvious limitation, but being an ongoing program, future data will reveal if these initial findings persist.

TECHNOLOGY AND THE "NORMAL" IN THE CORONAVIRUS ERA

2021 ◽  
Keyword(s):  
Social Isolation ◽  
Personal Development ◽  
Professional Life ◽  
Digital Platforms ◽  
Wearable Technologies ◽  
Technological Growth ◽  
Follow Up Care ◽  
Before And After ◽  
The Moment

Pandemic, although devastating in some aspects, is spreading rapidly as is technological growth. In times of social isolation, so much has never been learned through digital platforms, jobs are reinvented at unparalleled speed. Patients are treated in telehealth, a technology that stands out at the moment, a useful tool for initial or follow-up care. Real-time monitoring with GPS, Google platforms, wearable technologies, a range of options still without legislation and correct coverage. Reflecting on your personal and professional life, the Coronavirus, for sure, will divide our existence into before and after, and what was “normal” before, will remain unchanged afterwards? Reflections on technology, management and personal development.

Follow-up Care for Infants With Chronic Lung Disease: A Randomized Comparison of Community- and Center-Based Models

PEDIATRICS ◽  
2007 ◽  
Vol 119 (4) ◽  
pp. e947-e957 ◽  
Author(s):  
T. M. O'Shea ◽  
S. Nageswaran ◽  
D. C. Hiatt ◽  
C. Legault ◽  
M. L. Moore ◽  
...  
Keyword(s):  
Lung Disease ◽  
Chronic Lung Disease ◽  
Follow Up Care

Urban Study Uses Follow-Up Care to Prevent RSV

2007 ◽  
Vol 41 (1) ◽  
pp. 23
Author(s):  
BRUCE K. DIXON
Keyword(s):  
Urban Study ◽  
Follow Up Care
Sign in / Sign up

Export Citation Format

Share Document